WO2004053051A3 - Gelatine-based materials as swabs - Google Patents

Gelatine-based materials as swabs Download PDF

Info

Publication number
WO2004053051A3
WO2004053051A3 PCT/DK2003/000855 DK0300855W WO2004053051A3 WO 2004053051 A3 WO2004053051 A3 WO 2004053051A3 DK 0300855 W DK0300855 W DK 0300855W WO 2004053051 A3 WO2004053051 A3 WO 2004053051A3
Authority
WO
WIPO (PCT)
Prior art keywords
gelatine
swab
swabs
based materials
high recovery
Prior art date
Application number
PCT/DK2003/000855
Other languages
French (fr)
Other versions
WO2004053051A2 (en
Inventor
John E Hansen
Nikolaj Haulrik
Original Assignee
Ferrosan As
John E Hansen
Nikolaj Haulrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As, John E Hansen, Nikolaj Haulrik filed Critical Ferrosan As
Priority to US10/538,918 priority Critical patent/US7955288B2/en
Priority to JP2004557825A priority patent/JP2006509502A/en
Priority to BR0317237-6A priority patent/BR0317237A/en
Priority to EP03812570A priority patent/EP1573295A2/en
Priority to MXPA05006193A priority patent/MXPA05006193A/en
Priority to CN200380108960XA priority patent/CN1739017B/en
Priority to CA002509914A priority patent/CA2509914A1/en
Priority to AU2003302906A priority patent/AU2003302906B2/en
Publication of WO2004053051A2 publication Critical patent/WO2004053051A2/en
Publication of WO2004053051A3 publication Critical patent/WO2004053051A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0291—Instruments for taking cell samples or for biopsy for uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/38—Swabs having a stick-type handle, e.g. cotton tips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N2001/028—Sampling from a surface, swabbing, vaporising

Abstract

A swab comprising gelatine or collagen has been found to have a remarkably high recovery of microorganisms. Furthermore, the samples, such as microorganisms, spores, nucleotides and other biologically or biochemically relevant compounds can be fully recovered from the collagen-or gelatine-comprising swab. The invention thus provides a method and swab which has a high recovery of a target from a sample and furthermore a second high recovery when transferring from the swab to a medium for analysis.
PCT/DK2003/000855 2002-12-11 2003-12-11 Gelatine-based materials as swabs WO2004053051A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US10/538,918 US7955288B2 (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs
JP2004557825A JP2006509502A (en) 2002-12-11 2003-12-11 Gelatin-based material as a swab
BR0317237-6A BR0317237A (en) 2002-12-11 2003-12-11 Sampling or collecting device, kit, uses of a device and a kit, and methods for decreasing the amount of a marker in a sample area, for qualitatively or quantitatively sampling an area for the content of a marker and for grow microorganisms or mammalian cells collected
EP03812570A EP1573295A2 (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs
MXPA05006193A MXPA05006193A (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs.
CN200380108960XA CN1739017B (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs
CA002509914A CA2509914A1 (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs
AU2003302906A AU2003302906B2 (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43223202P 2002-12-11 2002-12-11
US60/432,232 2002-12-11
DKPA200201896 2002-12-11
DKPA200201896 2002-12-11

Publications (2)

Publication Number Publication Date
WO2004053051A2 WO2004053051A2 (en) 2004-06-24
WO2004053051A3 true WO2004053051A3 (en) 2005-03-10

Family

ID=36081240

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2003/000855 WO2004053051A2 (en) 2002-12-11 2003-12-11 Gelatine-based materials as swabs

Country Status (10)

Country Link
US (1) US7955288B2 (en)
EP (1) EP1573295A2 (en)
JP (1) JP2006509502A (en)
CN (1) CN1739017B (en)
AU (1) AU2003302906B2 (en)
BR (1) BR0317237A (en)
CA (1) CA2509914A1 (en)
MX (1) MXPA05006193A (en)
PL (1) PL377477A1 (en)
WO (1) WO2004053051A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121379A1 (en) * 2002-10-11 2004-06-24 Ohan Mark Peter Methods and devices for acquisition of genetic material
DE10311981A1 (en) * 2003-03-12 2004-09-23 Oligene Gmbh Device for application, extraction and storage of biological material, includes immobilizing substrate for e.g. diagnosis, therapy or application
ITMI20030643A1 (en) 2003-04-01 2004-10-02 Copan Innovation Ltd BUFFER FOR THE COLLECTION OF BIOLOGICAL SAMPLES
EP1786480B1 (en) * 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
EP1938756A1 (en) * 2006-12-29 2008-07-02 Qiagen GmbH Method and materials for triggered release of a biological sample
US8062608B2 (en) 2007-05-17 2011-11-22 Advance Dx, Inc. Fluid separator collection card
US7829340B2 (en) * 2007-08-06 2010-11-09 Oft Labs, Llc Oral fluid assays for the detection of heavy metal exposure
DE102007044648B4 (en) * 2007-09-18 2020-11-26 Carl Freudenberg Kg Bioresorbable gelatin non-woven fabric
US8628953B2 (en) 2007-11-29 2014-01-14 Hitachi Plant Technologies, Ltd. Capturing carrier, capturing device, analysis system using the same, and method for capturing and testing microorganisms
US20110059482A1 (en) * 2008-03-12 2011-03-10 Hector Roldan Sampling Kit
FR2949477A1 (en) * 2009-09-03 2011-03-04 Millipore Corp METHOD AND DEVICE FOR SAMPLING SURFACE ANALYSIS
US8420385B2 (en) 2010-04-21 2013-04-16 Puritan Medical Products Company, Llc Collection device and material
IT1401447B1 (en) * 2010-06-09 2013-07-26 Copan Italia Spa METHOD FOR THE QUANTITATIVE TRANSFER OF ANALYTES
IT1403618B1 (en) 2011-01-05 2013-10-31 Copan Italia Spa PROCEDURE FOR REALIZING A DEVICE FOR THE COLLECTION AND TRANSFER OF SAMPLES FOR MOLECULAR BIOLOGY
JP6241624B2 (en) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ／エス Pressurized container containing hemostatic paste
ITMI20121603A1 (en) 2012-09-25 2014-03-26 Copan Italia Spa DEVICE AND METHOD FOR THE COLLECTION AND TRANSFER OF SAMPLES OF BIOLOGICAL MATERIAL
US10088397B2 (en) 2013-06-19 2018-10-02 Advance Dx, Inc. Fluid separator collection card assembly
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10946376B2 (en) * 2013-07-05 2021-03-16 Thinxxs Microtechnology Ag Carrier element for introducing a dry substance into a flow cell
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
JP6726852B2 (en) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス Dry composition for use in hemostasis and wound healing
JP6747650B2 (en) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス Syringe for holding and mixing the first substance and the second substance
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN105255718A (en) * 2015-10-16 2016-01-20 广东海大集团股份有限公司 Testing cotton swab as well as preparation method and testing method thereof
US10532128B2 (en) * 2015-11-18 2020-01-14 Viera Bioscience, Inc. Implantable cellular therapy device for treatment of graft versus host disease and tolerance induction
US10610862B2 (en) 2016-04-04 2020-04-07 Advance Dx, Inc. Multiple path sample collection card
CA3075771A1 (en) 2017-09-21 2019-03-28 Becton, Dickinson And Company Reactive demarcation template for hazardous contaminant testing
US11385146B2 (en) 2017-09-21 2022-07-12 Becton, Dickinson And Company Sampling systems and techniques to collect hazardous contaminants with high pickup and shedding efficiencies
AU2018337035B2 (en) 2017-09-21 2023-10-12 Becton, Dickinson And Company Demarcation template for hazardous contaminant testing
US10916058B2 (en) 2017-09-21 2021-02-09 Becton, Dickinson And Company Augmented reality devices for hazardous contaminant testing
WO2019060270A1 (en) 2017-09-21 2019-03-28 Becton, Dickinson And Company High dynamic range assays in hazardous contaminant testing
EP3684944A4 (en) 2017-09-21 2021-05-26 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN111108380B (en) 2017-09-21 2022-11-01 贝克顿·迪金森公司 Hazardous contaminant collection kit and rapid test
CN108414295B (en) * 2018-03-07 2021-06-29 广东诺瓦安评检测有限公司 Sampling device and sampling method for industrial enzyme mixed dust in air of workplace
JP7395113B2 (en) 2018-05-09 2023-12-11 フェロサン メディカル デバイシーズ エイ／エス Method of preparing a hemostatic composition
EP3918300A4 (en) 2019-01-28 2022-11-16 Becton, Dickinson and Company Hazardous contaminant collection device with integrated swab and test device
KR20240019261A (en) * 2021-06-07 2024-02-14 리전츠 오브 더 유니버스티 오브 미네소타 Methods and materials for detecting prion diseases

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
GB697603A (en) * 1948-10-06 1953-09-23 Sydney Arthur Gladstone Improvements in or relating to method of and devices for obtaining tissue from a tumour carried by a patient
US3224434A (en) * 1962-11-06 1965-12-21 Waldemar Medical Res Foundatio Cell collector
US3815580A (en) * 1972-08-31 1974-06-11 C Oster Apparatus for and method of collecting and preserving cytologic samples
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4492305A (en) * 1983-07-08 1985-01-08 Marion Laboratories, Inc. Package for collecting cultures
EP0156649A2 (en) * 1984-03-29 1985-10-02 Minnesota Mining And Manufacturing Company Sorbent sheet material
US4997753A (en) * 1985-04-04 1991-03-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US5462860A (en) * 1994-06-06 1995-10-31 Minnesota Mining And Manufacturing Company Conditioned culture medium for rapid growth and detection of microbes
EP0702081A2 (en) * 1994-09-19 1996-03-20 Gunze Limited Matrix for tissue culture, method for culturing tissue, method for fixing cultured tissue and artificial skin fixed
WO1998043092A1 (en) * 1997-03-24 1998-10-01 Baystate Medical Center Method for determining the presence of mutated brca protein
WO1999012032A1 (en) * 1997-09-04 1999-03-11 Pharmacia & Upjohn Company A method for the evaluation of antiviral drugs
US5939259A (en) * 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
US6045570A (en) * 1997-02-11 2000-04-04 Biointerventional Corporation Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method
WO2001034206A2 (en) * 1999-11-09 2001-05-17 Cmic Co., Ltd. Nucleic acid-containing complex
US6261596B1 (en) * 1993-04-02 2001-07-17 Anticancer, Inc. Method to provide for production of hair coloring pigments in hair follicles
US20010041913A1 (en) * 1998-05-01 2001-11-15 Cragg Andrew H. Device and method for facilitating hemostasis of a biopsy tract
US20020010482A1 (en) * 1997-10-03 2002-01-24 Watt Paul W. Biopolymer sponge tubes, surgical staplers and methods of use thereof

Family Cites Families (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465860A (en) 1945-10-13 1949-03-29 Standard Manifold Company Inc Carbon holder
GB648619A (en) 1947-03-19 1951-01-10 Ferrosan As Process of producing sponges of gelatine and the like proteins
CH264752A (en) 1947-06-03 1949-10-31 Hoffmann La Roche Process for the manufacture of carriers for pharmaceuticals.
US3869539A (en) 1966-12-01 1975-03-04 Ferrosan As Preparations containing fat-soluble vitamins in dry, particulate, free-flowing form dispersible in cold water and method of producing such preparations
CA930128A (en) * 1969-10-21 1973-07-17 Torr David Fiber products containing water-absorbent material
US3678933A (en) 1970-07-17 1972-07-25 Moore Perk Corp Surgical sponge or bandage
FR2167197B1 (en) 1972-01-10 1974-06-21 Pont Brule Sa IMPROVED COMPOSITIONS CONTAINING GELATIN
US4280954A (en) 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
GB1584080A (en) 1977-12-05 1981-02-04 Ethicon Inc Absorbable hemostatic composition
US4265233A (en) 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
DE2943520C2 (en) 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Process for the production of collagen sponge for medical or cosmetic purposes
US4460642A (en) * 1981-06-26 1984-07-17 Minnesota Mining And Manufacturing Company Water-swellable composite sheet of microfibers of PTFE and hydrophilic absorptive particles
DE3146841A1 (en) 1981-11-26 1983-06-01 Beiersdorf Ag, 2000 Hamburg Wound-treatment compositions
JPS5928472A (en) 1982-08-09 1984-02-15 Koken:Kk Substrate for cell culture, cultivation and separation of cell using it
US4515637A (en) 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4522302A (en) 1984-03-05 1985-06-11 Sterling Drug Inc. Pre-sterilized medical procedure kit packages
US4717667A (en) * 1984-07-11 1988-01-05 Fmc Corporation Colony replicating device
JPS6144825A (en) 1984-08-09 1986-03-04 Unitika Ltd Hemostatic agent
JPS61122222A (en) 1984-11-19 1986-06-10 Koken:Kk Hemostatic agent composed of collagen or gelatin and protamine
JPS61209590A (en) 1985-03-13 1986-09-17 Asama Kasei Kk Novel immobilized cell and method for fermentative production utilizing same
US4861714A (en) 1985-04-04 1989-08-29 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US4863856A (en) 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
AT382783B (en) 1985-06-20 1987-04-10 Immuno Ag DEVICE FOR APPLICATING A TISSUE ADHESIVE
US5112750A (en) 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4696812A (en) 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
US5180583A (en) 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
US20020192271A1 (en) 1985-11-26 2002-12-19 Hedner Ulla Karin Elisabeth Method for causing local hemostasis and hemostatic composition for local hemostasis
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
JPS6485653A (en) 1987-09-28 1989-03-30 Terumo Corp Drug receiving container
IT1219587B (en) 1988-05-13 1990-05-18 Fidia Farmaceutici SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
EP0365705A1 (en) 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopreparation for the treatment of wounds
US4891359A (en) 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
JPH03217051A (en) * 1990-01-23 1991-09-24 Oki Electric Ind Co Ltd Semiconductor memory
US4982769A (en) 1990-02-21 1991-01-08 Survival Technology, Inc. Package
JPH0813750B2 (en) 1990-03-01 1996-02-14 持田製薬株式会社 Oral thrombin formulation
US5595735A (en) 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
EP0478827B1 (en) 1990-10-04 1994-04-06 Kallies Import-Export Vertrieb Gmbh Stabilized thrombine, its preparation and its use as a clotting-time agent
JP2990789B2 (en) * 1990-11-14 1999-12-13 東レ株式会社 Culture method of vascular endothelial cells
US5690675A (en) 1991-02-13 1997-11-25 Fusion Medical Technologies, Inc. Methods for sealing of staples and other fasteners in tissue
US5749895A (en) 1991-02-13 1998-05-12 Fusion Medical Technologies, Inc. Method for bonding or fusion of biological tissue and material
CA2103727A1 (en) 1991-02-13 1992-08-14 Philip N. Sawyer Filler material for use in tissue welding
US5669934A (en) 1991-02-13 1997-09-23 Fusion Medical Technologies, Inc. Methods for joining tissue by applying radiofrequency energy to performed collagen films and sheets
ES2084335T3 (en) 1991-02-14 1996-05-01 Baxter Int UNION OF LIPOSOMAS RECOGNITION SUBSTANCES.
DE4119140C2 (en) 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Porous spongeoid moldings soluble in body fluids and secretions, their preparation and use
FR2679772B1 (en) 1991-08-02 1995-05-19 Peters Sa EMBOLS IN NON-RESORBABLE PARTICLES COATED WITH HEMOSTATIC MATERIAL.
IT1251151B (en) 1991-08-05 1995-05-04 Fidia Spa SPONGY MATERIAL ESSENTIALLY CONSTITUTED BY HYALURONIC ACID, OR ITS DERIVATIVES
US6620436B1 (en) 1991-10-09 2003-09-16 Lectec Corporation Mixing and dispensing package for a wound dressing
GB9206509D0 (en) * 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
GB2266239B (en) 1992-03-25 1996-03-06 Jevco Ltd Wound healing compositions containing chondroitin sulphate oligosaccharides
IL105529A0 (en) 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
US5443481A (en) 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
AU4926193A (en) 1992-09-21 1994-04-12 Vitaphore Corporation Embolization plugs for blood vessels
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
JP3237799B2 (en) * 1993-04-06 2001-12-10 オリンパス光学工業株式会社 Automatic cleaning equipment for continuous processing tools for various liquids
WO1994023788A1 (en) 1993-04-20 1994-10-27 Medchem Products, Inc. Apparatus and method for applying a particulate hemostatic agent to living tissue
US5723308A (en) 1993-05-14 1998-03-03 Minnesota Mining And Manufacturing Company Culture medium for rapid count of coliform bacteria
US5951583A (en) 1993-05-25 1999-09-14 Vascular Solutions, Inc. Thrombin and collagen procoagulant and process for making the same
US5387208A (en) 1993-07-26 1995-02-07 The Procter & Gamble Co. Absorbent core having improved dry/wet integrity
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US5394886A (en) 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
EP0726749B1 (en) 1993-11-03 2004-08-11 Clarion Pharmaceuticals, Inc. Hemostatic patch
SG47996A1 (en) 1993-12-30 1998-04-17 Nitta Gelatin Kk Method for culturing animal cells under embedded conditions
DE4407875C2 (en) 1994-03-04 1996-04-04 Ankerpharm Gmbh Ankerwerk Rudo Medical sponge made from bioabsorbable materials, process and device for its production
ITPD940054A1 (en) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl SULPHATED POLYSACCHARIDES
CA2146090C (en) 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
US5931165A (en) 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
FR2726571B1 (en) 1994-11-03 1997-08-08 Izoret Georges BIOLOGICAL GLUE, PREPARATION METHOD AND APPLICATION DEVICE FOR BIOLOGICAL GLUE, AND HARDENERS FOR BIOLOGICAL GLUE
JPH08140692A (en) * 1994-11-25 1996-06-04 Toray Ind Inc Production of von wilebrand factor
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5804203A (en) * 1994-12-21 1998-09-08 Cosmederm Technologies Topical product formulations containing strontium for reducing skin irritation
ATE244584T1 (en) 1995-01-16 2003-07-15 Baxter Int SELF-SUPPORTING SURFACES MADE OF CROSS-LINKED FIBRIN FOR INHIBITING POSTOPERATIVE ADHESIONS
DE19513666C1 (en) 1995-04-11 1996-11-28 Behringwerke Ag Device for bringing together a first liquid and a second solid or liquid component by means of negative pressure under sterile conditions
JP3799626B2 (en) 1995-04-25 2006-07-19 有限会社ナイセム Cardiovascular repair material and method for producing the same
DE19521324C1 (en) 1995-06-12 1996-10-31 Immuno Ag Tissue adhesive and use thereof as a hemostatic
AU7398196A (en) 1995-10-11 1997-04-30 Fusion Medical Technologies, Inc. Device and method for sealing tissue
CA2251475C (en) 1996-04-04 2006-09-05 Immuno Aktiengesellschaft Hemostatic sponge based on collagen
US5948427A (en) 1996-04-25 1999-09-07 Point Medical Corporation Microparticulate surgical adhesive
US5791352A (en) 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
AU3720097A (en) 1996-07-12 1998-02-09 Baxter International Inc. A fibrin delivery device and method for forming fibrin on a surface
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
CA2211629A1 (en) 1996-09-17 1998-03-17 Bernard Sams Vial connector assembly for a medicament container
US5795330A (en) 1996-10-10 1998-08-18 Etex Corporation Mixing device
US5743412A (en) * 1996-11-13 1998-04-28 Chrysler Corporation Modular parts supply rack
US5782860A (en) 1997-02-11 1998-07-21 Biointerventional Corporation Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method
US5905029A (en) * 1997-02-19 1999-05-18 Fritz Berthold Method for rapid hygiene testing
FR2759980A1 (en) 1997-02-25 1998-08-28 Bras Michel Container for mixable food ingredients
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US20020039594A1 (en) 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US5908054A (en) 1997-06-16 1999-06-01 Fusion Medical Technologies, Inc. Fluid dispersion and delivery assembly and method
US5957166A (en) 1997-06-16 1999-09-28 Fusion Medical Technologies, Inc. Method and apparatus for dispersing fluid into a material
AU7977298A (en) 1997-06-18 1999-01-04 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
ZA987019B (en) 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
JPH1156343A (en) * 1997-08-21 1999-03-02 Able Kk Fixed bed reactor for culturing animal cell and sowing of cell
AU742675B2 (en) 1997-08-22 2002-01-10 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, method of its production and medical material containing it
US6168788B1 (en) 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
JP3483753B2 (en) 1997-12-29 2004-01-06 タキロン株式会社 Biodegradable absorbent plastic adhesive
US7722671B1 (en) * 1998-01-27 2010-05-25 St. Jude Medical, Inc. Medical devices with associated growth factors
US6099952A (en) 1998-02-18 2000-08-08 Xomed Surgical Products, Inc. Medical sponge having mucopolysaccharide coating
ATE371472T1 (en) 1998-03-06 2007-09-15 Baxter Int TURBULENCY MIXING HEAD FOR TISSUE ADHESIVE APPLICATOR AND SPRAY HEAD FOR THE SAME
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US20020061842A1 (en) 1998-04-10 2002-05-23 Octapharma Ag Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses
ITPD980169A1 (en) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl AMIDES OF HYALURONIC ACID AND ITS DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
US6334865B1 (en) 1998-08-04 2002-01-01 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
US6613070B2 (en) 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
WO2000007505A1 (en) 1998-08-04 2000-02-17 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
US20020015724A1 (en) 1998-08-10 2002-02-07 Chunlin Yang Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
AU754458B2 (en) 1998-12-23 2002-11-14 Csl Behring Gmbh Fibrin-based glue granulate and corresponding production method
US6283933B1 (en) * 1998-12-23 2001-09-04 Closure Medical Corporation Applicator for dispensable liquids
DE60018814T2 (en) 1999-01-21 2006-04-06 Nipro Corp. Sewable membrane for adhesion prevention
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
CA2371833C (en) 1999-02-19 2009-09-15 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel composition, process for its production and medical material containing it
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
EP1053758A1 (en) 1999-05-19 2000-11-22 Resorba Chirurgisches Nahtmaterial Franz Hiltner GmbH & Co. Bioabsorbable implant
US20020019062A1 (en) * 1999-06-18 2002-02-14 Peter Lea Assay devices
JP2003508564A (en) 1999-08-27 2003-03-04 コヒージョン テクノロジーズ， インコーポレイテッド Composition forming an interpenetrating polymer network for use as a high strength medical sealant
US20030095993A1 (en) 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
IT1317832B1 (en) 2000-02-15 2003-07-15 Eurores S R L PROCEDURE FOR THE PREPARATION OF MICRONIZED COLLAGEN AND THERAPEUTIC APPLICATIONS.
JP2003535620A (en) 2000-02-18 2003-12-02 リジェネレーション テクノロジーズ インク． Transplant tissue implanted with growth factors and other additives
EP1149906A1 (en) 2000-04-25 2001-10-31 Pliva, Farmaceutska, Industrija, Dionicko Drustvo Thrombopoietin receptor modulating peptide
AU2001259177A1 (en) 2000-04-28 2001-11-12 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
AT412445B (en) 2000-06-20 2005-03-25 Biering Wolfgang LIQUID COLLAGE HEMOSTATIC
AU2001273432A1 (en) * 2000-07-13 2002-01-30 Invitrogen Corporation Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
US20030032143A1 (en) 2000-07-24 2003-02-13 Neff Thomas B. Collagen type I and type III compositions for use as an adhesive and sealant
ATE392907T1 (en) 2000-07-28 2008-05-15 Anika Therapeutics Inc BIOABSORBABLE COMPOSITE MATERIALS MADE OF DERIVATIZED HYALURONIC ACID
US6890342B2 (en) 2000-08-02 2005-05-10 Loma Linda University Method and apparatus for closing vascular puncture using hemostatic material
IT1317358B1 (en) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl CROSS-LINKATED DERIVATIVES OF HYALURONIC ACID.
US6364519B1 (en) 2000-09-26 2002-04-02 Smith & Nephew, Inc. Bone cement system
US6458380B1 (en) 2000-11-09 2002-10-01 Richard Leaderman Dressing and preparation delivery system
US6635272B2 (en) 2000-11-09 2003-10-21 Richard N. Leaderman Wound dressing and drug delivery system
US20030009194A1 (en) 2000-12-07 2003-01-09 Saker Mark B. Tissue tract sealing device
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US20020164322A1 (en) 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
US6733774B2 (en) 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
BR0102637A (en) 2001-05-17 2003-02-25 Johnson & Johnson Ind Com Adhesive bandage
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
JP4668510B2 (en) 2001-09-29 2011-04-13 持田製薬株式会社 Pharmaceutical composition for local hemostasis in a flexible container
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US20060189516A1 (en) 2002-02-19 2006-08-24 Industrial Technology Research Institute Method for producing cross-linked hyaluronic acid-protein bio-composites
CN101898004A (en) 2002-02-20 2010-12-01 21世纪国际新技术株式会社 The device of drug administration
JP4624678B2 (en) 2002-02-21 2011-02-02 パイオニア・サージカル・オーソバイオロジックス，インコーポレイテッド Cross-linked bioactive hydrogel matrix
US20050137512A1 (en) 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
US20040101546A1 (en) 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20040120993A1 (en) 2002-12-20 2004-06-24 Guanghui Zhang Hemostatic wound dressing and fabric and methods of making and using same
US7713551B2 (en) 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040079763A1 (en) 2002-10-29 2004-04-29 Powell Cindy Hagood Duplex storage pouch
US7112713B2 (en) 2003-03-12 2006-09-26 Gelsus Research And Consulting, Inc. Dressing based on the Teorell-Meyer gradient
US7129210B2 (en) 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7109163B2 (en) 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
US20050218541A1 (en) 2004-04-02 2005-10-06 Peng Henry T Method of producing interpenetrating polymer network
US20050245905A1 (en) 2004-04-30 2005-11-03 Schmidt Steven P Local drug-delivery system
GB2414021A (en) 2004-05-10 2005-11-16 Johnson & Johnson Medical Ltd Absorbable haemostatic materials
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
EP1786480B1 (en) 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US20110097402A1 (en) 2004-09-30 2011-04-28 Covalon Technologies Inc. Non-adhesive elastic gelatin matrices
US9114194B2 (en) 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8496953B2 (en) 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US20080095830A1 (en) 2006-10-20 2008-04-24 Van Holten Robert W Method for making a dressing
US20080311172A1 (en) 2007-04-25 2008-12-18 Schapira Jay N Programmed-release, nanostructured biological construct
US20090087569A1 (en) 2007-09-27 2009-04-02 Fenchem Enterprises Ltd. Methods for Preparing Highly Stable Hyaluronic Acid

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
GB697603A (en) * 1948-10-06 1953-09-23 Sydney Arthur Gladstone Improvements in or relating to method of and devices for obtaining tissue from a tumour carried by a patient
US3224434A (en) * 1962-11-06 1965-12-21 Waldemar Medical Res Foundatio Cell collector
US3815580A (en) * 1972-08-31 1974-06-11 C Oster Apparatus for and method of collecting and preserving cytologic samples
US4098728A (en) * 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4492305A (en) * 1983-07-08 1985-01-08 Marion Laboratories, Inc. Package for collecting cultures
EP0156649A2 (en) * 1984-03-29 1985-10-02 Minnesota Mining And Manufacturing Company Sorbent sheet material
US4997753A (en) * 1985-04-04 1991-03-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US6261596B1 (en) * 1993-04-02 2001-07-17 Anticancer, Inc. Method to provide for production of hair coloring pigments in hair follicles
US5462860A (en) * 1994-06-06 1995-10-31 Minnesota Mining And Manufacturing Company Conditioned culture medium for rapid growth and detection of microbes
EP0702081A2 (en) * 1994-09-19 1996-03-20 Gunze Limited Matrix for tissue culture, method for culturing tissue, method for fixing cultured tissue and artificial skin fixed
US6045570A (en) * 1997-02-11 2000-04-04 Biointerventional Corporation Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method
WO1998043092A1 (en) * 1997-03-24 1998-10-01 Baystate Medical Center Method for determining the presence of mutated brca protein
US5939259A (en) * 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
WO1999012032A1 (en) * 1997-09-04 1999-03-11 Pharmacia & Upjohn Company A method for the evaluation of antiviral drugs
US20020010482A1 (en) * 1997-10-03 2002-01-24 Watt Paul W. Biopolymer sponge tubes, surgical staplers and methods of use thereof
US20010041913A1 (en) * 1998-05-01 2001-11-15 Cragg Andrew H. Device and method for facilitating hemostasis of a biopsy tract
WO2001034206A2 (en) * 1999-11-09 2001-05-17 Cmic Co., Ltd. Nucleic acid-containing complex

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
QUINTAVALLA J ET AL: "Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 23, no. 1, 1 January 2002 (2002-01-01), pages 109 - 119, XP004322626, ISSN: 0142-9612 *
SPENCE A M ET AL: "CEREBELLAR CAPILLARY HEMANGIOBLASTOMA: ITS HISTOGENESIS STUDIED BY ORGAN CULTURE AND ELECTRON MICROSCOPY", CANCER, AMERICAN CANCER SOCIETY, PHILADELPHIA, PA, US, vol. 35, no. 2, 1975, pages 326 - 341, XP009007586, ISSN: 0008-543X *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition

Also Published As

Publication number Publication date
BR0317237A (en) 2005-11-01
PL377477A1 (en) 2006-02-06
JP2006509502A (en) 2006-03-23
MXPA05006193A (en) 2005-12-05
EP1573295A2 (en) 2005-09-14
CA2509914A1 (en) 2004-06-24
US7955288B2 (en) 2011-06-07
AU2003302906B2 (en) 2009-04-02
CN1739017A (en) 2006-02-22
WO2004053051A2 (en) 2004-06-24
CN1739017B (en) 2011-04-06
US20060115805A1 (en) 2006-06-01
AU2003302906A1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
WO2004053051A3 (en) Gelatine-based materials as swabs
AU2003240327A1 (en) Composition and methods for obtaining nucleic acids from sputum
CA2354379A1 (en) Method for isolating dna from biological materials
IL176522A0 (en) Universal amplification of fragmented rna
WO2003008636A3 (en) Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
WO2003016552A3 (en) Dna purification and recovery from high particulate and solids samples
WO2002086107A3 (en) A method for differentiating stem cells into insulin-producing cells
AU2002249837A1 (en) Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
WO2005010209A3 (en) Method for the reverse transcription and/or amplification of nucleic acids
EP2166110A4 (en) SCREENING METHOD UTILIZING NOVEL SUBSTRATE EphA4 FOR GAMMA-SECRETASE
WO2005042060A3 (en) Method and composition comprising pyruvate, inosine, adenine, phosphate and an aziridino compound for treating a biological sample
WO2004027081A3 (en) Methods and composition for detecting targets
WO2004087879A3 (en) Pufa polyketide synthase systems and uses thereof
WO2003076037A3 (en) Selective elution of immobilized multiplexed primer extension products
Kisková et al. Analysis of the bacterial community from high alkaline (pH> 13) drainage water at a brown mud disposal site near Žiar nad Hronom (Banská Bystrica region, Slovakia) using 454 pyrosequencing
WO2001006004A3 (en) A method for amplifying low abundance nucleic acid sequences and means for performing said method
WO2003034025A3 (en) Methods and reagents for improved cell-based assays
WO2009154650A3 (en) Method for removing antibiotics from blood culture samples
AU2003257133A1 (en) Methods, devices and kits for multiplex blotting of biological samples from multi-well plates
AU4397101A (en) Method and kit for the detection of schistosomiasis through the polymerase chainreaction
WO2005079531A3 (en) Method and system for eluting cells
AUPS064202A0 (en) Improved method for the analysis of nucleic acid samples
AU2003270814A1 (en) Method of extracting nucleic acids from microbial samples
WO2004085618A3 (en) Method of screening for target ligands
EP0989192A3 (en) Method for synthesis of nucleic acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/006193

Country of ref document: MX

Ref document number: 377477

Country of ref document: PL

WWE Wipo information: entry into national phase

Ref document number: 2509914

Country of ref document: CA

Ref document number: 2004557825

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003302906

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2986/DELNP/2005

Country of ref document: IN

REEP Request for entry into the european phase

Ref document number: 2003812570

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003812570

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 20038A8960X

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2003812570

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0317237

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2006115805

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10538918

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10538918

Country of ref document: US